Ad copy

For 16 years nobody in the Western supplement industry wanted to talk about this study. The reason is not complicated. A research team following 30,000 Japanese adults across 16 years documented something that made an entire category of arterial health supplements look like they had been aimed at the wrong target the entire time. Read More: https://www.buymaia.com/shocking-discovery-nattokinase-plaque Not slightly off. Fundamentally. Mechanistically. At the wrong target entirely. The adults in the study who consumed nattokinase — a specific fibrinolytic enzyme derived from fermented soybeans, used daily in traditional Japanese medicine for over 1,000 years — showed arterial wellness markers 25% better than comparable populations who did not. Not in a short clinical window. Across 16 years of daily consumption. The kind of result that doesn't come from a temporary effect. The kind that comes from something aimed at the mechanism. Here is what the Western arterial health conversation has been missing. And why the thing you are most likely taking right now for your arterial health was never going to produce what this study documented. Arterial plaque does not accumulate because of what arrives at your artery wall. It accumulates where the fibrinolytic environment inside your artery wall allows it to. Your body runs a specific enzymatic process — fibrinolytic enzyme activity — whose function is to break down fibrin. Fibrin is the structural protein that gives arterial plaque its architecture. Its density. Its ability to anchor to the wall and accumulate into the kind of buildup that shows up on scans years after it started and earns a phrase like we'll want to keep an eye on this. Read More: https://www.buymaia.com/shocking-discovery-nattokinase-plaque When fibrinolytic activity is adequate your artery walls maintain active resistance to that accumulation. When it declines — which it does in virtually every adult after 50, measurably, without a symptom — the resistance breaks down. The wall becomes more permissive. The accumulation that was slow becomes faster. And here is what the 16-year study confirmed that the supplement industry has spent years hoping you wouldn't put together. Beet juice does not support fibrinolytic activity. Arginine does not support fibrinolytic activity. Fish oil, CoQ10, magnesium, and every blend with an impressive label that lines the shelves of every supplement retailer in America does not support fibrinolytic activity. None of them are aimed at the mechanism the 30,000-person study was measuring. Nattokinase is. It is the only compound with 1,000 years of traditional use and a 16-year population study and clinical trials across 1,000+ participants all pointing at the same mechanism — the fibrinolytic enzyme activity that determines whether your arterial walls accumulate or resist. The trials specified the concentration. 5,000 FU of nattokinase activity per serving. Read More: https://www.buymaia.com/shocking-discovery-nattokinase-plaque FU — fibrinolytic units — is the measure of active enzyme concentration. The number that tells you whether a nattokinase supplement is delivering what the research was conducted on or a diluted version of it. Most products don't reach 5,000 FU. Cheap fermentation. Low-grade sourcing. Enzyme activity that degrades in extraction. The label says nattokinase. The verified fibrinolytic activity arrives at your system at a fraction of the concentration the studies used and the outcomes reflected. MAÏA Nattokinase delivers 5,000 FU per serving. Pharmaceutical-grade. Japanese-sourced. Third-party verified at the concentration the 16-year population data and the 1,000-participant clinical trials were conducted on. Not an approximation. The number. Adults over 50 who have made it their daily habit describe what happens when the fibrinolytic mechanism finally gets what it was designed to work with. The cold in the hands and feet that had been there for years starting to lift within the first weeks. The afternoon energy that had been collapsing at 2pm beginning to hold. The arterial wellness conversation at the next checkup ending differently than every one before it. Not because something dramatic happened. Because the mechanism that governs whether their artery walls accumulate or resist was finally being supported directly. Read More: https://www.buymaia.com/shocking-discovery-nattokinase-plaque For the first time. The 16-year study did not make mainstream news. The 30,000 adults it followed were not the target market for the products it made look inadequate. But the mechanism it confirmed has been running in traditional Japanese practice for over a millennium. And the enzyme that supports it is available right now. MAÏA Nattokinase. 5,000 FU. Pharmaceutical-grade. Japanese-sourced. One capsule every morning. This is what the study found. This is what the supplement industry didn't want to be the headline. This is what was missing from every arterial health protocol built around the wrong target. 👉 Read the full research breakdown and see what 10,000+ adults over 50 are experiencing when their fibrinolytic system finally gets what it needs: https://www.buymaia.com/shocking-discovery-nattokinase-plaque On availability. MAÏA sources pharmaceutical-grade nattokinase from Japan in small verified batches to protect the 5,000 FU potency the research was conducted on. Stock sells out with regularity. Restocking takes months. The study has been sitting there for 16 years. The window to act on it is now.